StockData
Akebia Therapeutics, Inc. logo

Akebia Therapeutics, Inc. (AKBA) stock

AKBANasdaqPharmaceutical PreparationsFiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Nov 5, 2026Score 6/30
$0.40−0.05 (-10.74%)

Close on Nov 17, 2026Market cap $110.95MP/E –Yield –

Akebia Therapeutics market cap

Market capitalization is the share price multiplied by the number of shares outstanding.

Akebia Therapeutics's market cap was $155.90M on Nov 11, 2026, against $419.06M a year earlier. Over the last 5 years it ranged from $46.75M to $964.16M, with a median of $289.05M.

Market Cap at the end of each year

PeriodPeriod endValueChange
2026Nov 11, 2026$155.90M-63.5%
2025Dec 31, 2025$427.01M+6.2%
2024Dec 31, 2024$401.93M+72.1%
2023Dec 29, 2023$233.51M+120.0%
2022Dec 30, 2022$106.14M-73.1%
2021Dec 31, 2021$394.49M-1.7%
2020Dec 31, 2020$401.32M-46.6%
2019Dec 31, 2019$751.22M+138.1%
2018Dec 31, 2018$315.47M-55.1%
2017Dec 29, 2017$702.43M+76.4%
2016Dec 30, 2016$398.22M+2.0%
2015Dec 31, 2015$390.42M+65.2%
2014Dec 31, 2014$236.29M–

More Akebia Therapeutics figures

See a number that looks wrong?